[go: up one dir, main page]

PL3319638T3 - Kompozycja zawierająca cyneol do leczenia chorób nowotworowych i/lub raków - Google Patents

Kompozycja zawierająca cyneol do leczenia chorób nowotworowych i/lub raków

Info

Publication number
PL3319638T3
PL3319638T3 PL16733901T PL16733901T PL3319638T3 PL 3319638 T3 PL3319638 T3 PL 3319638T3 PL 16733901 T PL16733901 T PL 16733901T PL 16733901 T PL16733901 T PL 16733901T PL 3319638 T3 PL3319638 T3 PL 3319638T3
Authority
PL
Poland
Prior art keywords
cineol
tumours
cancers
treatment
containing composition
Prior art date
Application number
PL16733901T
Other languages
English (en)
Inventor
Markus UNKAUF
Barbara WOLLENBERG
Ralph Pries
Original Assignee
Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh filed Critical Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh
Publication of PL3319638T3 publication Critical patent/PL3319638T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL16733901T 2015-10-23 2016-06-20 Kompozycja zawierająca cyneol do leczenia chorób nowotworowych i/lub raków PL3319638T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE102015013668 2015-10-23
DE102015013725 2015-10-26
DE102015119552.6A DE102015119552B4 (de) 2015-10-23 2015-11-12 Monoterpenhaltige Zusammensetzung zur Behandlung von Tumor- und/oder Krebserkrankungen
EP16733901.9A EP3319638B1 (de) 2015-10-23 2016-06-20 Cineolhaltige zusammensetzung zur behandlung von tumor- und/oder krebserkrankungen
PCT/EP2016/064159 WO2017067676A1 (de) 2015-10-23 2016-06-20 Cineolhaltige zusammensetzung zur behandlung von tumor- und/oder krebserkrankungen

Publications (1)

Publication Number Publication Date
PL3319638T3 true PL3319638T3 (pl) 2020-06-01

Family

ID=57352252

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16733901T PL3319638T3 (pl) 2015-10-23 2016-06-20 Kompozycja zawierająca cyneol do leczenia chorób nowotworowych i/lub raków

Country Status (5)

Country Link
EP (1) EP3319638B1 (pl)
DE (2) DE202015106125U1 (pl)
ES (1) ES2768981T3 (pl)
PL (1) PL3319638T3 (pl)
WO (1) WO2017067676A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112494621A (zh) * 2020-12-17 2021-03-16 成都医学院 草果挥发油在制备治疗鼻咽癌的药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010080692A (ko) * 1998-12-07 2001-08-22 스티븐 엠. 베셋트 천연 식물 향유를 이용한 암 치료용 조성물 및 방법
FR2811899B1 (fr) * 2000-07-20 2003-02-07 Anne Marie Pierrette Giraud Association d'huiles essentielles et applications therapeutiques
FR2956817B1 (fr) 2010-02-26 2020-11-20 Oreal Utilisation d'huile essentielle d'origan ou de bois de rose, ou leurs constituants, dans le traitement therapeutique des keratoses
TWI582239B (zh) * 2013-03-11 2017-05-11 諾華公司 與wnt抑制劑相關之標記

Also Published As

Publication number Publication date
DE102015119552A1 (de) 2017-04-27
WO2017067676A1 (de) 2017-04-27
ES2768981T3 (es) 2020-06-24
EP3319638A1 (de) 2018-05-16
DE102015119552B4 (de) 2022-06-15
DE202015106125U1 (de) 2016-10-27
EP3319638B1 (de) 2019-12-04

Similar Documents

Publication Publication Date Title
HK1249524A1 (zh) 用於治療血載癌症的免疫檢查點抑制劑
HK1256283A1 (zh) 治療癌症有用的二氫咪唑並吡嗪酮衍生物
ZA201607415B (en) Antibody-drug-conjugate and its use for the treatment of cancer
IL310069B1 (en) RAD1901 for use in cancer treatment
SG11201700079VA (en) Combination therapy compositions and methods for treating cancers
ZA201900960B (en) Methods and compositions for the treatment of cancer
IL259996A (en) Combinations for cancer treatment
LT3458052T (lt) Vėžio kombinuotas gydymas
IL263793A (en) Compounds and preparations for the treatment of cancer
IL280587B (en) Fluorocitidine derivatives and their preparations for use in cancer treatment
ZA201901578B (en) Combinations including abx196 for the treatment of cancer
HK1255695A1 (zh) 用於治療眼瞼下垂的組合物和方法
IL255169A0 (en) Treatment combination of an anti-pogatactic factor and an immunotherapy factor and compounds for the treatment of cancer
ZA201707024B (en) Cancer treatment composition
IL269121A (en) Usl-311 for use in the treatment of cancer
HK1258843A1 (zh) 糖脂化合物及其在治療腫瘤中的用途
SG11202000724XA (en) Methods and compositions for the treatment of cancer
PL3319638T3 (pl) Kompozycja zawierająca cyneol do leczenia chorób nowotworowych i/lub raków
IL255167A0 (en) Compounds for the treatment of cancer
IL255168A0 (en) Treatment combination of an anti-pogatactic factor and an anti-cancer factor and compounds for the treatment of cancer